Yara International Valuation

Is 0O7D undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0O7D when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
NOK 385.88
Fair Value
10.5% undervalued intrinsic discount
19
Number of Analysts

Below Fair Value: 0O7D (NOK345.4) is trading below our estimate of fair value (NOK385.88)

Significantly Below Fair Value: 0O7D is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0O7D?

Key metric: As 0O7D is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0O7D. This is calculated by dividing 0O7D's market cap by their current earnings.
What is 0O7D's PE Ratio?
PE Ratio29.3x
EarningsUS$290.00m
Market CapUS$8.43b

Price to Earnings Ratio vs Peers

How does 0O7D's PE Ratio compare to its peers?

The above table shows the PE ratio for 0O7D vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.6x
CRDA Croda International
27.9x14.43%UK£4.4b
JMAT Johnson Matthey
4.3x-29.40%UK£2.3b
MNDI Mondi
28.6x21.19%UK£5.2b
FRES Fresnillo
69.7x31.54%UK£7.4b
0O7D Yara International
29.3x20.60%NOK 87.9b

Price-To-Earnings vs Peers: 0O7D is good value based on its Price-To-Earnings Ratio (29.3x) compared to the peer average (32.6x).


Price to Earnings Ratio vs Industry

How does 0O7D's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0O7D 29.3xIndustry Avg. 17.7xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0O7D is expensive based on its Price-To-Earnings Ratio (29.3x) compared to the European Chemicals industry average (17.7x).


Price to Earnings Ratio vs Fair Ratio

What is 0O7D's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0O7D PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.3x
Fair PE Ratio21.4x

Price-To-Earnings vs Fair Ratio: 0O7D is expensive based on its Price-To-Earnings Ratio (29.3x) compared to the estimated Fair Price-To-Earnings Ratio (21.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0O7D forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentNOK 342.86
NOK 357.66
+4.32%
13.99%NOK 435.00NOK 270.00n/a19
May ’26NOK 341.01
NOK 356.03
+4.41%
14.16%NOK 435.00NOK 270.00n/a19
Apr ’26NOK 317.50
NOK 353.47
+11.33%
13.44%NOK 435.00NOK 270.00n/a19
Mar ’26NOK 319.04
NOK 352.03
+10.34%
13.52%NOK 435.00NOK 270.00n/a19
Feb ’26NOK 339.45
NOK 351.06
+3.42%
15.01%NOK 435.00NOK 250.00n/a19
Jan ’26NOK 300.19
NOK 350.16
+16.64%
15.40%NOK 435.00NOK 250.00n/a19
Dec ’25NOK 309.34
NOK 351.25
+13.55%
14.80%NOK 435.00NOK 250.00n/a18
Nov ’25NOK 331.84
NOK 350.40
+5.59%
15.18%NOK 435.00NOK 250.00n/a18
Oct ’25NOK 336.98
NOK 347.25
+3.05%
14.76%NOK 435.00NOK 280.00n/a17
Sep ’25NOK 308.80
NOK 346.67
+12.26%
15.02%NOK 435.00NOK 270.00n/a17
Aug ’25NOK 308.86
NOK 352.04
+13.98%
15.64%NOK 435.00NOK 270.00n/a17
Jul ’25NOK 306.91
NOK 352.10
+14.72%
16.42%NOK 435.00NOK 270.00n/a17
Jun ’25NOK 324.66
NOK 354.78
+9.28%
15.77%NOK 435.00NOK 270.00n/a17
May ’25NOK 318.38
NOK 370.87
+16.48%
14.62%NOK 448.73NOK 280.00NOK 341.0117
Apr ’25NOK 342.90
NOK 381.12
+11.15%
11.70%NOK 439.06NOK 300.00NOK 317.5017
Mar ’25NOK 343.50
NOK 386.17
+12.42%
11.63%NOK 435.00NOK 300.00NOK 319.0417
Feb ’25NOK 349.19
NOK 385.36
+10.36%
14.51%NOK 460.00NOK 260.00NOK 339.4516
Jan ’25NOK 361.75
NOK 397.64
+9.92%
13.31%NOK 475.00NOK 300.00NOK 300.1916
Dec ’24NOK 361.20
NOK 399.58
+10.63%
13.39%NOK 475.00NOK 300.00NOK 309.3416
Nov ’24NOK 363.20
NOK 402.89
+10.93%
12.85%NOK 475.00NOK 320.00NOK 331.8416
Oct ’24NOK 405.33
NOK 416.05
+2.65%
13.06%NOK 505.00NOK 320.00NOK 336.9817
Sep ’24NOK 387.48
NOK 412.50
+6.46%
13.43%NOK 505.00NOK 320.00NOK 308.8018
Aug ’24NOK 413.09
NOK 411.41
-0.41%
13.23%NOK 505.00NOK 320.00NOK 308.8618
Jul ’24NOK 379.13
NOK 433.29
+14.29%
13.24%NOK 520.00NOK 330.00NOK 306.9118
Jun ’24NOK 412.76
NOK 441.76
+7.03%
12.83%NOK 525.00NOK 350.00NOK 324.6618
May ’24NOK 428.72
NOK 456.59
+6.50%
13.42%NOK 540.00NOK 360.00NOK 318.3818
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
NOK 354.79
Fair Value
2.6% undervalued intrinsic discount
19
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 18:44
End of Day Share Price 2025/05/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Yara International ASA is covered by 63 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Andrew BensonÅlandsbanken Equities Research Ab
Stephen WilderAlliance Global Partners